Evidence map›Paper›PMID 17289675›Full record

ArticleThe Journal of biological chemistry2007

Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.

Brian D Thompson, Yongzhu Jin, Kevin H Wu, Richard A Colvin, Andrew D Luster, Lutz Birnbaumer, Mei X Wu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Nurr1 Orchestrates Claustrum Development and Functionality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Protective effects of GαNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. GαJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  16. Article
  17. Pancreatic islet inflammation: an emerging role for chemokines.Journal of molecular endocrinology · 2017
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brian D ThompsonWellman Center for Photomedicine, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114.
Yongzhu JinWellman Center for Photomedicine, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114.
Kevin H WuWellman Center for Photomedicine, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114.
Richard A ColvinCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Andrew D LusterCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Lutz BirnbaumerNIEHS, Transmembrane Signaling Group, Laboratory of Signal Transduction, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Mei X WuWellman Center for Photomedicine, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114. Electronic address: mwu2@partners.org.
Harvard University · USMassachusetts General Hospital · USNational Institute of Environmental Health Sciences · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
DERMATOLOGY TRAINING GRANTT32AR007098 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI THOMAS S. KUPPER · 1986 to 2026
$8.1M
Transmembrane Signaling MechanismsZ01ES101643 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BIRNBAUMER, LUTZ · 2003 to 2008
$5.1M
Biochemical and Genetic Dissection of Chemokine Receptor CXCR3 SignalingR01DK074449 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2005 to 2009
$1.7M
Autoimmunity in IEX-1- transgenic miceR01AI050822 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2003 to 2006
$1.3M
IEX-1 in bridge of innate to adaptive immune responses to memory T cellsK02AI070785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2006 to 2010
$531k
Intramural NIH HHS Z01 ES101643NIAID NIH HHS AI050822NIAID NIH HHS AI070785NIAID NIH HHS K02 AI070785NIAID NIH HHS R01 AI050822NIAMS NIH HHS T32 AR007098NIAMS NIH HHS T32 AR07098-31NIDDK NIH HHS DK074449NIDDK NIH HHS DK43351NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK074449
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) convey extracellular stimulation into dynamic intracellular action, leading to the regulation of cell migration and differentiation. T lymphocytes express G alpha(i2) and G alpha(i3), two members of the G alpha(i/o) protein family, but whether these two G alpha(i) proteins have distinguishable roles guiding T cell migration remains largely unknown because of a lack of member-specific inhibitors. This study details distinct G alpha(i2) and G alpha(i3) effects on chemokine receptor CXCR3-mediated signaling. Our data showed that G alpha(i2) was indispensable for T cell responses to three CXCR3 ligands, CXCL9, CXCL10, and CXCL11, as the lack of G alpha(i2) abolished CXCR3-stimulated migration and guanosine 5'-3-O-(thio)triphosphate (GTPgammaS) incorporation. In sharp contrast, T cells isolated from G alpha(i3) knock-out mice displayed a significant increase in both GTPgammaS incorporation and migration as compared with wild type T cells when stimulated with CXCR3 agonists. The increased GTPgammaS incorporation was blocked by G alpha(i3) protein in a dose-dependent manner. G alpha(i3)-mediated blockade of G alpha(i2) activation did not result from G alpha(i3) activation, but instead resulted from competition or steric hindrance of G alpha(i2) interaction with the CXCR3 receptor via the N terminus of the second intracellular loop. A mutation in this domain abrogated not only G alpha(i2) activation induced by a CXCR3 agonist but also the interaction of G alpha(i3) to the CXCR3 receptor. These findings reveal for the first time an interplay of G alpha(i) proteins in transmitting G protein-coupled receptor signals. This interplay has heretofore been masked by the use of pertussis toxin, a broad inhibitor of the G alpha(i/o) protein family.

Indexed as

AnimalsCells, CulturedChemokine CXCL10Chemokine CXCL11Chemokine CXCL9Chemokines, CXCFemaleGTP-Binding Protein alpha Subunit, Gi2GTP-Binding Protein alpha Subunits, Gi-GoMaleMiceMice, Inbred C57BLMice, KnockoutReceptors, ChemokineReceptors, CXCR3Signal TransductionChemokine CXCL10Chemokine CXCL11Chemokine CXCL9Chemokines, CXCCxcl10 protein, mouseCxcl11 protein, mouseCxcl9 protein, mouseCxcr3 protein, mouseGnai3 protein, mouseGTP-Binding Protein alpha Subunit, Gi2GTP-Binding Protein alpha Subunits, Gi-GoReceptors, ChemokineReceptors, CXCR3

Identifiers

PMID17289675
PMCPMC2366813
OpenAlexW1527489726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.